Tag: iv solutions market size

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Veterinary Intravenous (IV) Solutions Market?

The veterinary intravenous (IV) solutions market is projected to expand due to an uptick in the occurrence of several animal diseases. Animal diseases, which can impact an animal’s health and functionality, include conditions like anthrax, leptospirosis, rabies, and canine distemper, among others. The increased frequency of such diseases can be attributed to factors like intensive farming habits, wildlife overrun, and resistance to antibiotics. These IV solutions are crucial for animals suffering from diseases that cause dehydration, like severe infections or gastroenteritis, as they help maintain hydration levels and support overall health. For example, AVMA Publications, the publishing division of the American Veterinary Medical Association, reported in July 2024 that approximately 345 domestic animals were confirmed to have rabies in 2022, reflecting a 10.9% hike from the 311 cases in 2021. Hence, the rise in animal disease prevalence is propelling the veterinary IV solutions market.

Veterinary Intravenous (IV) Solutions Driver: Growing Spending on Animal Health Products Fuels Veterinary IV Solutions Market

 

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20686&type=smp

How Will the Growth Rate of theVeterinary Intravenous (IV) Solutions Market Impact Industry Trends by 2034?

The market size of veterinary intravenous (IV) solutions has witnessed significant growth recently. It is predicted to increase from $1.5 billion in 2024 to $1.62 billion in 2025 with a compound annual growth rate (CAGR) of 8.1%. Factors responsible for this expansion in the historical phase include the growth in the count of veterinary clinics, an increase in dehydration cases, a surge in livestock farming, a boost in the numbers of pets, and advances in veterinary diagnostics.

It is projected that the veterinary intravenous (IV) solutions market will experience significant growth in the coming years. The value of the market is expected to reach $2.19 billion by 2029, with a compound annual growth rate (CAGR) of 7.8%. The predicted growth during the forecast period can be linked to factors such as the growing acceptance of pet insurance, an increase in animal healthcare expenses, heightened awareness of animal health care, a rise in the prevalence of animal diseases, and an expansion in pet insurance coverage. Key trends forecasted for this period involve technological advancements, variation in product formulations, the inclusion of telemedicine, the development of superior veterinary intravenous (IV) delivery systems, and the emergence of intelligent veterinary intravenous (IV) systems.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20686

What Are the Key Market Innovations in theVeterinary Intravenous (IV) Solutions Market Over the Coming Years?

Prominent companies in the veterinary intravenous (IV) solutions market are now prioritizing the development of advanced products like fluoroquinolone to enhance their effectiveness and safety metrics. Fluoroquinolones represent a potent category of antibiotics deployed in both human and veterinary healthcare to combat various bacterial infections, with the option for careful management to reduce the likelihood of resistance and adverse effects. For example, Elanco, a pharmaceutical company out of the United States, unveiled Pradalex, a pradofloxacin injection solution in April 2024 that received approval from the U.S. Food and Drug Administration (FDA). The U.S health organization gave clearance for its use in swine, aimed at tackling swine respiratory disease (SRD) linked to bordetella bronchiseptica, Glaesserella (Haemophilus) parasuis, Pasteurella multocida, streptococcus suis, and mycoplasma hyopneumoniae. Pradalex, as a 3rd generation fluoroquinolone, is rated as a critically important antimicrobial. The labeling on the drug emphasizes that it should only be employed after other non-fluoroquinolone therapeutic solutions have been considered.

Who Are the Top Companies Driving Innovation and Growth in theVeterinary Intravenous (IV) Solutions Market?

Major companies operating in the veterinary intravenous (IV) solutions market are Merck & Co. Inc., Baxter International Inc., Zoetis Inc., Fresenius Kabi AG, Elanco Animal Health Incorporated, B. Braun Melsungen AG, Virbac SA, Dechra Pharmaceuticals PLC, Vetoquinol SA, Norbrook Laboratories Limited, Ceva Santé Animale, Revival Animal Health Inc., Aromor Animal Health, Jorgensen Laboratories LLC, Pharmacosmos AS, Sykes Veterinary International Pty Ltd., Rusoma Laboratories Private Limited, Patterson Companies Inc., NexGen Veterinary, Soxa Formulations & Research Pvt. Ltd

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/veterinary-intravenous-iv-solutions-global-market-report

Which Key Market Segments Comprise the Veterinary Intravenous (IV) Solutions Market and Drive Its Revenue Growth?

The veterinary intravenous (IV) solutions market covered in this report is segmented –

1) By Product: Isotonic Crystalloids, Dextrose Solutions, Synthetic Colloids, Natural Colloids, Parenteral Nutrition

2) By Animal Type: Companion Animals, Production Animals

3) By End-User: Veterinary Hospitals And Clinics, Research Institutes, Other End-Users

Subsegments:

1) Isotonic Crystalloids: Normal Saline (0.9% NaCl), Lactated Ringer’s Solution, Dextrose in Water (D5W), Ringer’s Solution, Balanced Electrolyte Solutions

2) Dextrose Solutions: Dextrose 5% in Water (D5W), Dextrose 10% in Water (D10W), Dextrose 20% in Water (D20W), Dextrose 50% in Water (D50W)

3) Synthetic Colloids: Hydroxyethyl Starch (HES), Dextran, Gelatins

4) Natural Colloids: Albumin, Fresh Frozen Plasma (FFP), Blood Products

5) Parenteral Nutrition: Total Parenteral Nutrition (TPN) Solutions, Partial Parenteral Nutrition Solutions, Lipid Emulsions, Amino Acid Solutions

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=20686&type=smp

Which Regions Are Emerging as Leaders in the Veterinary Intravenous (IV) Solutions Market?

North America was the largest region in the veterinary intravenous (IV) solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary intravenous (IV) solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Veterinary Intravenous (IV) Solutions Market 2025, By The Business Research Company:

Veterinary Biologics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-biologics-global-market-report

Veterinary Hematology Analyzers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-hematology-analyzers-global-market-report

Veterinary Telehealth Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-telehealth-market

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What key factors are powering the surge in the veterinary intravenous (iv) solutions market right now?

Over recent years, there has been a significant expansion in the market size for veterinary intravenous (IV) solutions. The market, which was valued at $1.5 billion in 2024, is forecasted to reach $1.62 billion in 2025, showing a compound annual growth rate (CAGR) of 8.1%. The previous period’s growth is due to factors such as the surge in the number of veterinary clinics and the rising incidences of dehydration. Further contributing factors include the expansion of livestock farming, the growing number of companion animals, and advancements in veterinary diagnostics.

How fast Is the veterinary intravenous (iv) solutions market expected to grow, and what’s its future value?

The market size for veterinary intravenous (IV) solutions is predicted to experience substantial expansion in the upcoming years. The expectations are that it will surge to $2.19 billion by 2029, with a compound annual growth rate (CAGR) of 7.8%. This projected growth can be tied to a surge in pet insurance adoption, increased spending on animal healthcare, enhanced awareness about animal health, escalating prevalence of animal diseases, and wider pet insurance coverage. Key trends during this forecasted period are expected to include technological progression, assorted product formulations, the incorporation of telemedicine, state-of-the-art veterinary intravenous (IV) delivery mechanisms, and intelligent veterinary intravenous (IV) systems.

Get your veterinary intravenous (iv) solutions market report here!

https://www.thebusinessresearchcompany.com/report/veterinary-intravenous-iv-solutions-global-market-report

What are the leading drivers of growth in the veterinary intravenous (iv) solutions market?

Expectations are that the rise in incidence of various animal disorders may trigger an upswing in the veterinary intravenous solutions sector. Such animal ailments that compromise their vitality and wellness include anthrax, leptospirosis, rabies, canine distemper, heartworm disease among others. Factors such as intensive farming techniques, wildlife intrusion, and antibiotic resistance are contributing to this proliferation. Veterinary IV solutions play a crucial role in rehydrating animals suffering from diseases that lead to dehydration like gastroenteritis or severe infections, thereby boosting overall health performance. AVMA Publications, a division of the American Veterinary Medical Association, cited a significant rise in domestic animal rabies cases in July 2024, with figures standing at 345 cases in 2022, up by 10.9% from the previous year’s 311 cases. This serves to emphasize the critical driver role played by increasing animal disease prevalence in escalating the veterinary intravenous solution market’s growth. The veterinary intravenous solutions market is expected to further thrive with rising expenditure on animal health commodities. These are drugs, supplements, and therapies crafted to enhance or maintain an animal’s state of health. Factors driving the upswing in expenditure on these products include increasing pet ownership, heightened consciousness of animal health, veterinary care technological progress, and the quest for superior disease prevention and intervention methods. Moreover, veterinary IV solutions actively contribute to escalated animal health product expenditure by answering to pressing healthcare needs and propelling veterinary care improvements. An illustrative case is the 6.9% growth in the veterinary medicinal products market in 2023, per data from the Republic of Estonia Agency of Medicines, a regulatory agency based in Estonia. The market value was pegged at $20.54 million, a marked increase from $19.21 million, the previous year’s value. Thus, the rise in expenditure on animal health products is a major driver for the growth of the veterinary intravenous solutions market.

What are the key segments defining the veterinary intravenous (iv) solutions market?

The veterinary intravenous (IV) solutions market covered in this report is segmented –

1) By Product: Isotonic Crystalloids, Dextrose Solutions, Synthetic Colloids, Natural Colloids, Parenteral Nutrition

2) By Animal Type: Companion Animals, Production Animals

3) By End-User: Veterinary Hospitals And Clinics, Research Institutes, Other End-Users

Subsegments:

1) Isotonic Crystalloids: Normal Saline (0.9% NaCl), Lactated Ringer’s Solution, Dextrose in Water (D5W), Ringer’s Solution, Balanced Electrolyte Solutions

2) Dextrose Solutions: Dextrose 5% in Water (D5W), Dextrose 10% in Water (D10W), Dextrose 20% in Water (D20W), Dextrose 50% in Water (D50W)

3) Synthetic Colloids: Hydroxyethyl Starch (HES), Dextran, Gelatins

4) Natural Colloids: Albumin, Fresh Frozen Plasma (FFP), Blood Products

5) Parenteral Nutrition: Total Parenteral Nutrition (TPN) Solutions, Partial Parenteral Nutrition Solutions, Lipid Emulsions, Amino Acid Solutions

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20686&type=smp

Who are the key players steering the development of the veterinary intravenous (iv) solutions market?

Major companies operating in the veterinary intravenous (IV) solutions market are Merck & Co. Inc., Baxter International Inc., Zoetis Inc., Fresenius Kabi AG, Elanco Animal Health Incorporated, B. Braun Melsungen AG, Virbac SA, Dechra Pharmaceuticals PLC, Vetoquinol SA, Norbrook Laboratories Limited, Ceva Santé Animale, Revival Animal Health Inc., Aromor Animal Health, Jorgensen Laboratories LLC, Pharmacosmos AS, Sykes Veterinary International Pty Ltd., Rusoma Laboratories Private Limited, Patterson Companies Inc., NexGen Veterinary, Soxa Formulations & Research Pvt. Ltd

What emerging trends are influencing the growth of the veterinary intravenous (iv) solutions market?

Leading firms in the veterinary intravenous (IV) solutions market are prioritizing the development of enhanced products like fluoroquinolones to bolster effectiveness and safety. Fluoroquinolones are potent antibiotics used in human and veterinary medicine to manage different bacterial infections, with careful administration to lessen the risk of resistance and side effects. In April 2024, for instance, Elanco, an American pharmaceutical company, introduced Pradalex, a pradofloxacin solution injected and approved by the US Food and Drug Administration (FDA), a US health body. The swine approval caters to the treatment of swine respiratory disease (SRD) linked with bordetella bronchiseptica, Glaesserella (Haemophilus) parasuis, Pasteurella multocida, streptococcus suis, and mycoplasma hyopneumoniae. Pradalex, a 3rd generation fluoroquinolone, is considered an extremely important antimicrobial. The packaging of the drug emphasizes that it should only be used if other non-fluoroquinolone treatments have been considered.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20686

Which regions are most influential in expanding the veterinary intravenous (iv) solutions market?

North America was the largest region in the veterinary intravenous (IV) solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary intravenous (IV) solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Veterinary Biologics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-biologics-global-market-report

Veterinary Hematology Analyzers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-hematology-analyzers-global-market-report

Veterinary Telehealth Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-telehealth-market

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What CAGR Will the Veterinary Intravenous (IV) Solutions Market Achieve During 2025–2034, and What Does It Indicate?

The market for veterinary intravenous (IV) solutions has experienced robust growth in the last few years. The market is expected to expand from $1.5 billion in 2024 to $1.62 billion in 2025, with a compound annual growth rate (CAGR) of 8.1%. Factors contributing to the growth during the historic period include an upsurge in the establishment of veterinary clinics, increased incidences of dehydration, expansion in livestock farming, growth in the count of companion animals, and advancement in veterinary diagnostics.

The market size for veterinary intravenous (IV) solutions is projected to experience a significant surge in the upcoming years, expanding to $2.19 billion in 2029 with a compound annual growth rate (CAGR) of 7.8%. Several factors contribute to this growth during the forecast period, such as the increased adoption of pet insurance, the rise in animal healthcare spending, an enhanced understanding of animal healthcare, an increase in animal disease cases, and an expansion in pet insurance coverage. The forecast period will likely see certain trends emerging, including technological progression, variety in product formulations, the incorporation of telemedicine, improved veterinary intravenous (IV) delivery systems, and intelligent veterinary intravenous (IV) systems.

Which Drivers Are Expected to Have the Greatest Impact on the Veterinary Intravenous (IV) Solutions Market’s Growth?

The escalation in various animal diseases is predicted to fuel the veterinary intravenous (IV) solutions market’s expansion. These diseases, such as anthrax, leptospirosis, rabies, canine distemper, heartworm disease, and others, impair animals’ health and functionality. Intensive farming practices, wildlife encroachment, and antibiotic resistance are some factors that contribute to this increase. Veterinary IV solutions play a critical role in providing optimal hydration and supporting the overall health of animals with diseases that cause dehydration, such as gastroenteritis or severe infections. For instance, AVMA Publications reported in July 2024 that the number of domestic animals confirmed with rabies in 2022 was around 345, a 10.9% increase from the 311 cases reported in 2021. Hence, the rise in various animal diseases is fueling the veterinary intravenous (IV) solutions market’s growth. The upswing in expenditure on animal health products is anticipated to stimulate the veterinary intravenous (IV) solutions market’s growth. Animal health products include medications, supplements, and treatments used for the betterment or maintenance of an animal’s health. Factors like growing pet ownership, advancements in veterinary care, increasing knowledge of animal health and the necessity for superior disease prevention and treatment options drive the higher spending on these products. Veterinary IV solutions aid this increase in expenditure on animal health products by addressing crucial medical needs and improving veterinary care. As reported by the Republic of Estonia Agency of Medicines in March 2024, the veterinary medicinal products market saw a 6.9% rise in 2023, reaching $20.54 million (18.6 million euros) from $19.21 million (17.40 million euros) in 2022. Thus, the rising expenditure on animal health products is propelling the veterinary intravenous (IV) solutions market’s growth.

Get Your Free Sample of the Global Veterinary Intravenous (IV) Solutions Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=20686&type=smp

Who Are the Key Firms Paving the Way for Growth in the Veterinary Intravenous (IV) Solutions Market?

Major companies operating in the veterinary intravenous (IV) solutions market are:

• Merck & Co. Inc.

• Baxter International Inc.

• Zoetis Inc.

• Fresenius Kabi AG

• Elanco Animal Health Incorporated

What Are the Most Influential Trends Currently Shaping the Veterinary Intravenous (IV) Solutions Market?

Key players in the veterinary intravenous (IV) solutions market are concentrating on the development of innovative products like fluoroquinolone, aimed at enhancing efficacy and security profiles. Fluoroquinolones are a potent category of antibiotics used in both human and veterinary medicine to treat a range of bacterial infections and managed properly to reduce the potential of resistance and side effects. For example, in April 2024, Elanco, a pharmaceutical company from the US, launched Pradalex, a pradofloxacin injection solution that received approval from the US Food and Drug Administration (FDA). This approval for swine is targeted at treating swine respiratory disease (SRD) related to bordetella bronchiseptica, Glaesserella (Haemophilus) parasuis, Pasteurella multocida, streptococcus suis, and mycoplasma hyopneumoniae. Being a 3rd generation fluoroquinolone, Pradalex is classified as a critically important antimicrobial. The medication’s labeling stipulates that its use should be considered only after exploring other non-fluoroquinolone therapeutic alternatives.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/veterinary-intravenous-iv-solutions-global-market-report

What Are the Major Segments of the Veterinary Intravenous (IV) Solutions Market and Their Role in Driving Growth?

The veterinary intravenous (IV) solutions market covered in this report is segmented –

1) By Product: Isotonic Crystalloids, Dextrose Solutions, Synthetic Colloids, Natural Colloids, Parenteral Nutrition

2) By Animal Type: Companion Animals, Production Animals

3) By End-User: Veterinary Hospitals And Clinics, Research Institutes, Other End-Users

Subsegments:

1) Isotonic Crystalloids: Normal Saline (0.9% NaCl), Lactated Ringer’s Solution, Dextrose in Water (D5W), Ringer’s Solution, Balanced Electrolyte Solutions

2) Dextrose Solutions: Dextrose 5% in Water (D5W), Dextrose 10% in Water (D10W), Dextrose 20% in Water (D20W), Dextrose 50% in Water (D50W)

3) Synthetic Colloids: Hydroxyethyl Starch (HES), Dextran, Gelatins

4) Natural Colloids: Albumin, Fresh Frozen Plasma (FFP), Blood Products

5) Parenteral Nutrition: Total Parenteral Nutrition (TPN) Solutions, Partial Parenteral Nutrition Solutions, Lipid Emulsions, Amino Acid Solutions

Which Regions Are Essential for the Growth of the Veterinary Intravenous (IV) Solutions Market?

North America was the largest region in the veterinary intravenous (IV) solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary intravenous (IV) solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Is the Scope and Reach of the Veterinary Intravenous (IV) Solutions Market Defined?

Veterinary intravenous (IV) solutions are sterile fluids administered directly into the bloodstream of animals through a vein, typically via an IV catheter. These solutions are used in veterinary medicine to treat dehydration and electrolyte imbalances, deliver medications, or provide nutrients. Veterinary intravenous (IV) solutions are essential for maintaining or restoring the proper fluid and electrolyte balance in animals, especially in illness, surgery, or trauma cases.

Browse Through More Similar Reports By The Business Research Company:

Veterinary Biologics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-biologics-global-market-report

Veterinary Hematology Analyzers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-hematology-analyzers-global-market-report

Veterinary Telehealth Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-telehealth-market

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: